Global Glucokinase Market By Product Type (LY-2608204, Sinogliatin) And By End-Users/Application (Metabolic Disorder, Obesity) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

  • AMR-984480
  • April 2021
  • Food
  • 112 Pages

Report Preview

The Glucokinase Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)

The Glucokinase Market has been valued at US$ xx Mn in the year 2020 and is anticipated to attain US$ xx Mn by the year 2028 along with a CAGR of xx%

Glucokinase Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Glucokinase market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2019
Forecast Period Covered 2019 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Product Type LY-2608204, Sinogliatin, AM-9514, TMG-123, TTP-399, Others
Applications Metabolic Disorder, Obesity, Diabetes, Others
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered Amgen Inc, Eli Lilly and Co, Ligand Pharmaceuticals Inc, Merck & Co Inc, Poxel SA, Teijin Pharma Ltd, vTv Therapeutics Inc, Yuhan Corp
 
Glucokinase Market Competitive and Premeditated Analysis
In the Glucokinase report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Glucokinase research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Glucokinase Market Segmentation Analysis:
The Glucokinase market is segmented into various sections such as product types, applications as well as end users and regions. Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

Segmentation based on type includes LY-2608204, Sinogliatin, AM-9514, TMG-123, TTP-399, Others   

The application segment includes   Metabolic Disorder, Obesity, Diabetes, Others

Major Key Players for Global Glucokinase Market:
The Glucokinase market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Amgen Inc, Eli Lilly and Co, Ligand Pharmaceuticals Inc, Merck & Co Inc, Poxel SA, Teijin Pharma Ltd, vTv Therapeutics Inc, Yuhan Corp
 
The Glucokinase market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Regional Analysis of the Glucokinase market:
The Glucokinase market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

The Global segmentation of the Glucokinase market:
By Type:
  • LY-2608204
  • Sinogliatin
  • AM-9514
  • TMG-123
  • TTP-399
  • Others

By Application
  • Metabolic Disorder
  • Obesity
  • Diabetes
  • Others

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


 
Major Factors Included and highlighted in the Glucokinase report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Glucokinase market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Glucokinase market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Glucokinase market is included in the report.
 
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Glucokinase market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Glucokinase market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Glucokinase market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Glucokinase market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Glucokinase market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Glucokinase Market Snapshot
          2.1.1. Global Glucokinase Market By Type,2019
               2.1.1.1.LY-2608204
               2.1.1.2.Sinogliatin
               2.1.1.3.AM-9514
               2.1.1.4.TMG-123
               2.1.1.5.TTP-399
               2.1.1.6.Others
          2.1.2. Global Glucokinase Market By Application,2019
               2.1.2.1.Metabolic Disorder
               2.1.2.2.Obesity
               2.1.2.3.Diabetes
               2.1.2.4.Others
          2.1.3. Global Glucokinase Market By End-use,2019
          2.1.4. Global Glucokinase Market By Geography,2019

3. Global Glucokinase Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Glucokinase Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Glucokinase Market Size (US$), By Type, 2018 – 2028

5. Global Glucokinase Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Glucokinase Market Size (US$), By Application, 2018 – 2028

6. Global Glucokinase Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Glucokinase Market Size (US$), By End-use, 2018 – 2028

7. Global Glucokinase Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Glucokinase Market Analysis, 2018 – 2028 
          7.2.1. North America Glucokinase Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Glucokinase Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Glucokinase Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Glucokinase Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Glucokinase Market Analysis, 2018 – 2028 
          7.3.1.  Europe Glucokinase Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Glucokinase Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Glucokinase Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Glucokinase Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Glucokinase Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Glucokinase Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Glucokinase Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Glucokinase Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Glucokinase Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Glucokinase Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Glucokinase Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Glucokinase Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Glucokinase Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Glucokinase Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Glucokinase Market Analysis, 2018 – 2028 
          7.6.1.  MEA Glucokinase Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Glucokinase Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Glucokinase Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Glucokinase Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Glucokinase Providers
        8.4.1 Amgen Inc
                8.1.1 Business Description
                8.1.2 Amgen Inc Geographic Operations
                8.1.3 Amgen Inc Financial Information
                8.1.4 Amgen Inc Product Positions/Portfolio
                8.1.5 Amgen Inc Key Developments
        8.4.2 Eli Lilly and Co
                8.2.1 Business Description
                8.2.2 Eli Lilly and Co Geographic Operations
                8.2.3 Eli Lilly and Co Financial Information
                8.2.4 Eli Lilly and Co Product Positions/Portfolio
                8.2.5 Eli Lilly and Co Key Developments
        8.4.3 Ligand Pharmaceuticals Inc
                8.3.1 Business Description
                8.3.2 Ligand Pharmaceuticals Inc Geographic Operations
                8.3.3 Ligand Pharmaceuticals Inc Financial Information
                8.3.4 Ligand Pharmaceuticals Inc Product Positions/Portfolio
                8.3.5 Ligand Pharmaceuticals Inc Key Developments
        8.4.4 Merck & Co Inc
                8.4.1 Business Description
                8.4.2 Merck & Co Inc Geographic Operations
                8.4.3 Merck & Co Inc Financial Information
                8.4.4 Merck & Co Inc Product Positions/Portfolio
                8.4.5 Merck & Co Inc Key Developments
        8.4.5 Poxel SA
                8.5.1 Business Description
                8.5.2 Poxel SA Geographic Operations
                8.5.3 Poxel SA Financial Information
                8.5.4 Poxel SA Product Positions/Portfolio
                8.5.5 Poxel SA Key Developments
        8.4.6 Teijin Pharma Ltd
                8.6.1 Business Description
                8.6.2 Teijin Pharma Ltd Geographic Operations
                8.6.3 Teijin Pharma Ltd Financial Information
                8.6.4 Teijin Pharma Ltd Product Positions/Portfolio
                8.6.5 Teijin Pharma Ltd Key Developments
        8.4.7 vTv Therapeutics Inc
                8.7.1 Business Description
                8.7.2 vTv Therapeutics Inc Geographic Operations
                8.7.3 vTv Therapeutics Inc Financial Information
                8.7.4 vTv Therapeutics Inc Product Positions/Portfolio
                8.7.5 vTv Therapeutics Inc Key Developments
        8.4.8 Yuhan Corp
                8.8.1 Business Description
                8.8.2 Yuhan Corp Geographic Operations
                8.8.3 Yuhan Corp Financial Information
                8.8.4 Yuhan Corp Product Positions/Portfolio
                8.8.5 Yuhan Corp Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Glucokinase Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Glucokinase Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Glucokinase Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Glucokinase Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Glucokinase Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Glucokinase Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Glucokinase Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Glucokinase Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Glucokinase Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Glucokinase Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Glucokinase Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Glucokinase Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Glucokinase Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Glucokinase Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Glucokinase Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Glucokinase Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Glucokinase: Market Segmentation 
FIG. 2 Global Glucokinase Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Glucokinase Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Glucokinase Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Glucokinase Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Glucokinase Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Glucokinase Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Glucokinase Providers, 2019
FIG. 11 Global Glucokinase Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Glucokinase Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Glucokinase Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Glucokinase Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Glucokinase Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Glucokinase Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Glucokinase Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Glucokinase Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Glucokinase market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Glucokinase Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Glucokinase Market Value, By Segment1, 2018 – 2028
TABLE  North America Glucokinase Market Value, By Segment2, 2018 – 2028
TABLE  North America Glucokinase Market Value, By Country, 2018 – 2028
TABLE  Europe Glucokinase Market Value, By Segment1, 2018 – 2028
TABLE  Europe Glucokinase Market Value, By Segment2, 2018 – 2028
TABLE  Europe Glucokinase Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Glucokinase Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Glucokinase Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Glucokinase Market Value, By Country, 2018 – 2028
TABLE  Latin America Glucokinase Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Glucokinase Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Glucokinase Market Value, By Country, 2018 – 2028
TABLE  MEA Glucokinase Market Value, By Segment1, 2018 – 2028
TABLE  MEA Glucokinase Market Value, By Segment2, 2018 – 2028
TABLE  MEA Glucokinase Market Value, By Country, 2018 – 2028
TABLE  Amgen Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Eli Lilly and Co: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Ligand Pharmaceuticals Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck & Co Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Poxel SA: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Teijin Pharma Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  vTv Therapeutics Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Yuhan Corp: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Glucokinase Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Glucokinase Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Glucokinase Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Glucokinase Market, By Geography, 2019 (US$ Mn)
FIG.  Global Glucokinase Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Glucokinase Providers, 2016
FIG.  Global Glucokinase Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global LY-2608204 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Sinogliatin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global AM-9514 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global TMG-123 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global TTP-399 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Glucokinase Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Metabolic Disorder Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Obesity Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Diabetes Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Glucokinase Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Glucokinase Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Glucokinase Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Glucokinase Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Glucokinase Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Glucokinase Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Glucokinase Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Glucokinase Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Glucokinase Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Glucokinase Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Glucokinase Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Glucokinase Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Glucokinase Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Glucokinase Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Glucokinase Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Glucokinase Market Value, 2018 – 2028, (US$ Mn)